Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc.
Atara Biotherapeutics
Bioniz Therapeutics
Morphotek
INSYS Therapeutics Inc